P. Larsson

3.3k total citations
90 papers, 2.5k citations indexed

About

P. Larsson is a scholar working on Molecular Biology, Electrical and Electronic Engineering and Cellular and Molecular Neuroscience. According to data from OpenAlex, P. Larsson has authored 90 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Electrical and Electronic Engineering and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in P. Larsson's work include Advancements in PLL and VCO Technologies (13 papers), Analog and Mixed-Signal Circuit Design (10 papers) and Low-power high-performance VLSI design (10 papers). P. Larsson is often cited by papers focused on Advancements in PLL and VCO Technologies (13 papers), Analog and Mixed-Signal Circuit Design (10 papers) and Low-power high-performance VLSI design (10 papers). P. Larsson collaborates with scholars based in Sweden, United States and Australia. P. Larsson's co-authors include C. Svensson, Udo Frese, Tom Duckett, Anna Rudin, Annica Dahlström, Kajsa Wing, Elisabeth Suri‐Payer, S Larsson, Sverker Jern and Helén Karlsson and has published in prestigious journals such as PLoS ONE, Gut and Biochemical and Biophysical Research Communications.

In The Last Decade

P. Larsson

87 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Larsson Sweden 25 741 500 388 267 248 90 2.5k
Hiroshi Miyakawa Japan 36 703 0.9× 424 0.8× 867 2.2× 99 0.4× 609 2.5× 185 4.7k
Kazuyuki Kobayashi Japan 28 235 0.3× 215 0.4× 597 1.5× 386 1.4× 203 0.8× 289 3.0k
Toru Tanaka Japan 31 376 0.5× 220 0.4× 622 1.6× 594 2.2× 264 1.1× 185 4.5k
Chun‐Jen Chen Taiwan 28 241 0.3× 809 1.6× 1.1k 2.9× 186 0.7× 226 0.9× 93 3.5k
Min Du China 30 284 0.4× 261 0.5× 398 1.0× 1.0k 3.9× 42 0.2× 173 3.0k
Yingwei Chen China 31 216 0.3× 423 0.8× 1.4k 3.6× 78 0.3× 379 1.5× 126 3.3k
Zhenhua Feng China 32 641 0.9× 181 0.4× 1.1k 2.7× 133 0.5× 459 1.9× 189 3.3k
Baoling Liu United States 35 308 0.4× 973 1.9× 1.4k 3.6× 61 0.2× 186 0.8× 140 3.3k
Peng Deng China 22 303 0.4× 166 0.3× 509 1.3× 133 0.5× 55 0.2× 118 2.1k
Akihiro Takahashi Japan 39 167 0.2× 1.3k 2.6× 931 2.4× 123 0.5× 662 2.7× 147 4.7k

Countries citing papers authored by P. Larsson

Since Specialization
Citations

This map shows the geographic impact of P. Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Larsson more than expected).

Fields of papers citing papers by P. Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Larsson. The network helps show where P. Larsson may publish in the future.

Co-authorship network of co-authors of P. Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of P. Larsson. A scholar is included among the top collaborators of P. Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Larsson. P. Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selan, Carly, David Wright, Robert Brkljača, et al.. (2025). Endothelial -targeted CD39 is protective in a mouse model of global forebrain ischaemia. Journal of Neuroinflammation. 22(1). 115–115. 1 indexed citations
2.
Larsson, P., et al.. (2024). Finding and following: a deep learning-based pipeline for tracking platelets during thrombus formation in vivo and ex vivo. Platelets. 35(1). 2344512–2344512. 2 indexed citations
3.
Larsson, P., et al.. (2023). PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic mice. Journal of Thrombosis and Haemostasis. 22(1). 249–254. 2 indexed citations
4.
Faxälv, Lars, et al.. (2023). Thrombus remodelling by reversible and irreversible P2Y 12 inhibitors. Platelets. 34(1). 2157805–2157805. 3 indexed citations
5.
Larsson, P., et al.. (2022). Phosphoinositide 3-Kinases as Potential Targets for Thrombosis Prevention. International Journal of Molecular Sciences. 23(9). 4840–4840. 5 indexed citations
6.
Draxler, Dominik F., Maria Daglas, Anushka Fernando, et al.. (2019). Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis. Journal of Thrombosis and Haemostasis. 17(12). 2174–2187. 22 indexed citations
7.
Daglas, Maria, Dominik F. Draxler, Heidi Ho, et al.. (2019). Activated CD8+ T Cells Cause Long-Term Neurological Impairment after Traumatic Brain Injury in Mice. Cell Reports. 29(5). 1178–1191.e6. 100 indexed citations
8.
Larsson, P., et al.. (2015). Dynamic Enhancer Methylation - A Previously Unrecognized Switch for Tissue-Type Plasminogen Activator Expression. PLoS ONE. 10(10). e0141805–e0141805. 7 indexed citations
9.
Svennerholm, Kristina, Michael Haney, Björn Biber, et al.. (2015). Histone Deacetylase Inhibition Enhances Tissue Plasminogen Activator Release Capacity in Atherosclerotic Man. PLoS ONE. 10(3). e0121196–e0121196. 8 indexed citations
10.
Larsson, P., Erik Ulfhammer, Niklas Bergh, et al.. (2012). Role of Histone Acetylation in the Stimulatory Effect of Valproic Acid on Vascular Endothelial Tissue-Type Plasminogen Activator Expression. PLoS ONE. 7(2). e31573–e31573. 41 indexed citations
11.
Larsson, P., Niklas Bergh, Erik Ulfhammer, et al.. (2012). Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells. Journal of Thrombosis and Thrombolysis. 35(2). 185–192. 13 indexed citations
12.
Ulfhammer, Erik, et al.. (2008). Suppression of endothelial t-PA expression by prolonged high laminar shear stress. Biochemical and Biophysical Research Communications. 379(2). 532–536. 5 indexed citations
13.
Larsson, P., Erik Ulfhammer, Lena Karlsson, et al.. (2008). Effects of IL-1β and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells. Thrombosis Research. 123(2). 342–351. 13 indexed citations
14.
Brisslert, Mikael, Maria Bokarewa, P. Larsson, et al.. (2006). Phenotypic and functional characterization of human CD25+ B cells. Immunology. 117(4). 548–557. 96 indexed citations
15.
Ulfhammer, Erik, P. Larsson, Linnéa Karlsson, et al.. (2006). TNF-α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-κB- and p38 MAPK-dependent. Journal of Thrombosis and Haemostasis. 4(8). 1781–1789. 36 indexed citations
16.
Cao, Duojia, Ola Börjesson, P. Larsson, et al.. (2006). FOXP3 Identifies Regulatory CD25brightCD4+ T Cells in Rheumatic Joints. Scandinavian Journal of Immunology. 63(6). 444–452. 57 indexed citations
17.
Abrahamsson, Kate, Sverker Hansson, P. Larsson, & Ulf Jodal. (2002). Antibiotic treatment for five days is effective in children with acute cystitis. Acta Paediatrica. 91(1). 55–58. 2 indexed citations
18.
Rosenborg, Johan, et al.. (2002). Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients. Respiratory Medicine. 96(6). 412–417. 22 indexed citations
19.
Larsson, S, et al.. (1994). The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?. European Respiratory Journal. 7(1). 94–101. 65 indexed citations
20.
Nilsson, Ove, Jean Cassuto, P. Larsson, et al.. (1983). 5-Hydroxytryptamine and cholera secretion: a histochemical and physiological study in cats.. Gut. 24(6). 542–548. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Miyakawa Breakdown of academic impact, for papers by Kazuyuki Kobayashi Breakdown of academic impact, for papers by Toru Tanaka Breakdown of academic impact, for papers by Chun‐Jen Chen Breakdown of academic impact, for papers by Min Du Breakdown of academic impact, for papers by Yingwei Chen Breakdown of academic impact, for papers by Zhenhua Feng Breakdown of academic impact, for papers by Baoling Liu Breakdown of academic impact, for papers by Peng Deng Breakdown of academic impact, for papers by Akihiro Takahashi
Rankless by CCL
2026